Literature DB >> 1904506

The necessary length of hospital stay for chronic pulmonary disease.

A I Mushlin1, E R Black, C A Connolly, K M Buonaccorso, S W Eberly.   

Abstract

OBJECTIVE: --To determine the necessary length of stay for patients admitted to the hospital with an exacerbation of chronic pulmonary disease and to compare this with the length of stay assigned by the diagnosis related group system.
DESIGN: --A cohort of patients were followed up prospectively after hospital admission to determine when complications, critical incidents, and the need for monitoring occurred. The medically derived necessary lengths of stay were statistically compared with the lengths of stay assigned by the diagnosis related group. Clinical factors were used to predict long vs short necessary lengths of stay.
SETTING: --Two acute care hospitals: one was the principal and the other a major community teaching hospital. PATIENTS: --A consecutive sample of 83 patients who were 45 years of age or older and who required admission for treatment of chronic pulmonary disease. MAIN OUTCOME MEASURES: --The occurrence and time of complications, critical interventions, and monitoring.
RESULTS: --After 6 days in the hospital, 90% of patients were free of complications or the need for monitoring. However, 16 days elapsed before 90% of patients had been discharged from the hospital. The length of stay that was considered necessary for care averaged 6.9 days; the actual mean length of stay was 8.7 days. The correlation between each patient's ideal length of stay and the length of stay assigned by the diagnosis related group was low and was not statistically significant. Three clinical variables at the time of admission (high PCO2 levels, symptoms that were present for more than 1 day, and antibiotic treatment) were associated with the need for longer hospital stays.
CONCLUSIONS: --The medically required length of stay for patients with an exacerbation of chronic pulmonary disease was between 6 and 7 days, on average. This length of stay, which was based on clinical events, differs from the length of stay that was calculated as a statistical norm by the diagnosis related group system. Clinical characteristics may help to identify patients who require a longer length of stay.

Entities:  

Mesh:

Year:  1991        PMID: 1904506

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  21 in total

Review 1.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

2.  Association between length of stay and readmission for COPD.

Authors:  Seppo T Rinne; Meredith C Graves; Lori A Bastian; Peter K Lindenauer; Edwin S Wong; Paul L Hebert; Chuan-Fen Liu
Journal:  Am J Manag Care       Date:  2017-08-01       Impact factor: 2.229

3.  Weak associations between hospital mortality rates for individual diagnoses: implications for profiling hospital quality.

Authors:  G E Rosenthal
Journal:  Am J Public Health       Date:  1997-03       Impact factor: 9.308

4.  Effectiveness and safety of an emergency department short-stay unit as an alternative to standard inpatient hospitalisation.

Authors:  A Juan; A Salazar; A Alvarez; J R Perez; L Garcia; X Corbella
Journal:  Emerg Med J       Date:  2006-11       Impact factor: 2.740

5.  Exploring models for the length of stay distribution.

Authors:  C Ruffieux; A Marazzi; F Paccaud
Journal:  Soz Praventivmed       Date:  1993

6.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

7.  Antimicrobials in acute exacerbations of chronic obstructive pulmonary disease - An analysis of the time to next exacerbation before and after the implementation of standing orders.

Authors:  Rob D Goddard; Shelly A McNeil; Kathryn L Slayter; R Andrew McIvor
Journal:  Can J Infect Dis       Date:  2003-09

8.  Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.

Authors:  Cecile M A Utens; Lucas M A Goossens; Frank W J M Smeenk; Onno C P van Schayck; Walter van Litsenburg; Annet Janssen; Monique van Vliet; Wiel Seezink; Dirk R A J Demunck; Brigitte van de Pas; Peter J de Bruijn; Anouschka van der Pouw; Jeroen M A M Retera; Petra de Laat-Bierings; Loes van Eijsden; Maria Braken; Riet Eijsermans; Maureen P M H Rutten-van Mölken
Journal:  BMC Public Health       Date:  2010-10-18       Impact factor: 3.295

9.  Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization.

Authors:  Katayoun Bahadori; J Mark FitzGerald; Robert D Levy; Tharwat Fera; John Swiston
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

Review 10.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

Authors:  Denis E O'Donnell; Shaw Aaron; Jean Bourbeau; Paul Hernandez; Darcy D Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Rogers Goldstein; Rick Hodder; Alan Kaplan; Sean Keenan; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.